Literature DB >> 21993970

Donor-specific HLA antibodies and graft function in children after renal transplantation.

Jenni Miettinen1, Juha Peräsaari, Jouni Lauronen, Erik Qvist, Helena Valta, Mikko Pakarinen, Jussi Merenmies, Hannu Jalanko.   

Abstract

BACKGROUND: The presence of circulating donor-specific human leukocyte antigen antibodies (HLA-DSA) has been associated with chronic antibody-mediated rejection, leading to progressive graft dysfunction and poor graft survival.The aim of this study was to investigate the incidence and significance of HLA-DSA in paediatric renal transplantation(RTx) patients.
METHODS: A total of 294 post-transplant serum samples from 123 RTx patients were retrospectively analysed for HLA antibodies. Positive samples were further tested for HLADSA by a Luminex Single Antigen bead assay. The antibody findings were correlated to measured glomerular filtration rate(GFR) and clinical outcome.
RESULTS: HLA antibodies were detected in half of the routine samples (140/294) taken 1 month to 10 years after RTx, and 40% (62/140) of these were HLA-DSA. Overall, one-third(42/123) of the patients had HLA-DSA, which mostly(65%) reacted against class II antigens. Detection of HLADSA was not associated with poor GFR at the time of sampling, and no exceptional deterioration of GFR after the HLA-DSA detection was noted in individual patients regardless of the antibody level. The presence of HLA-DSA in the first 2 years posttransplantation was not associated with poorer graft function later on.
CONCLUSION: Detection of HLA antibodies is common in children after RTx, and this finding, as such, does not predict any deterioration of graft function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993970     DOI: 10.1007/s00467-012-2101-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  32 in total

1.  Prospects and limitations of post-transplantation alloantibody detection in renal transplantation.

Authors:  Georg A Böhmig; Gregor Bartel; Heinz Regele; Markus Wahrmann
Journal:  Hum Immunol       Date:  2009-04-15       Impact factor: 2.850

Review 2.  Anti-HLA alloantibodies in pediatric solid organ transplantation.

Authors:  Alin L Girnita; Steven A Webber; Adriana Zeevi
Journal:  Pediatr Transplant       Date:  2006-03

3.  Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients.

Authors:  Clifford Chin; Ge Chen; Flavia Sequeria; Gerald Berry; Stephanie Siehr; Daniel Bernstein; David Rosenthal; Olaf Reinhartz; Dolly Tyan
Journal:  J Heart Lung Transplant       Date:  2010-10-15       Impact factor: 10.247

4.  The natural history of chronic allograft nephropathy.

Authors:  Brian J Nankivell; Richard J Borrows; Caroline L-S Fung; Philip J O'Connell; Richard D M Allen; Jeremy R Chapman
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

Review 5.  Human leukocyte antigen antibodies and chronic rejection: from association to causation.

Authors:  Paul I Terasaki; Junchao Cai
Journal:  Transplantation       Date:  2008-08-15       Impact factor: 4.939

6.  Summary of the effect of de novo HLA antibodies on chronic kidney graft failure.

Authors:  Paul Terasaki; Nils Lachmann; Junchao Cai
Journal:  Clin Transpl       Date:  2006

7.  Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor.

Authors:  Arun Gupta; Paul Sinnott
Journal:  Hum Immunol       Date:  2009-04-15       Impact factor: 2.850

8.  Donor-specific antibodies by flow single antigen beads in pediatric living donor kidney transplants: single center experience.

Authors:  Isabel Roberti; Shefali Vyas; Carol Pancoska
Journal:  Pediatr Transplant       Date:  2007-12

9.  Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.

Authors:  Nils Lachmann; Paul I Terasaki; Klemens Budde; Lutz Liefeldt; Andreas Kahl; Petra Reinke; Johann Pratschke; Birgit Rudolph; Danilo Schmidt; Abdulgabar Salama; Constanze Schönemann
Journal:  Transplantation       Date:  2009-05-27       Impact factor: 4.939

10.  Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.

Authors:  Hooi Sian Eng; Greg Bennett; Peter Bardy; Patrick Coghlan; Graeme R Russ; P Toby H Coates
Journal:  Hum Immunol       Date:  2009-06-12       Impact factor: 2.850

View more
  5 in total

Review 1.  Renal transplantation in infants.

Authors:  Hannu Jalanko; Ilkka Mattila; Christer Holmberg
Journal:  Pediatr Nephrol       Date:  2015-06-27       Impact factor: 3.714

Review 2.  Kidney disease in children: latest advances and remaining challenges.

Authors:  John F Bertram; Stuart L Goldstein; Lars Pape; Franz Schaefer; Rukshana C Shroff; Bradley A Warady
Journal:  Nat Rev Nephrol       Date:  2016-02-01       Impact factor: 28.314

Review 3.  Long-term outcomes of children after solid organ transplantation.

Authors:  Jon Jin Kim; Stephen D Marks
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

4.  Age-associated decrease in de novo donor-specific antibodies in renal transplant recipients reflects changing humoral immunity.

Authors:  Seraina von Moos; Gesa Schalk; Thomas F Mueller; Guido Laube
Journal:  Immun Ageing       Date:  2019-05-09       Impact factor: 6.400

5.  Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts.

Authors:  Michiel G H Betjes; Kasia S Sablik; Henny G Otten; Dave L Roelen; Frans H Claas; Annelies de Weerd
Journal:  J Transplant       Date:  2020-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.